Autopsy report · NCT00262353
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
Cause of deathSafety
“study never started because of safety alerts in literature regarding the topic to be examined”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- University Hospital, Ghent
- Sponsor type
- University, hospital or other
- Conditions
- Renal Failure, Chronic
- Interventions
- Dialysis with different artificial devices
- Participants
- 0
- Sites
- 1
- Countries
- Belgium
Trials that died the same way
- Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
“The study was stopped due to safety concerns” - Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
“Due to a safety signal found at a planned interim safety review, further conduct of this safety study is not recommended hence the study was terminated.” - An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis
“The study was stopped due to a non-clinical safety finding.” - Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
“Study stopped due to safety reasons.” - Stroke With Transfusions Changing to Hydroxyurea
“The study has been stopped due to safety and futility concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.